It's literally "crazy' how many new studies and potential indications apabetalone could be involved with due to MOA considerations and impact, especially once established as a "proven safe and effective" drug.

So much riding on BoM, well at least from a timing and progress perspective. These opportunities can all develop over extended periods of time, but hopefully positive TLD gets a lot of these things heading down the tracks sooner rather than later.